These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21859566)

  • 21. Oxaliplatin-Induced Peripheral Neuropathy and Identification of Unique Severity Groups in Colorectal Cancer.
    Griffith KA; Zhu S; Johantgen M; Kessler MD; Renn C; Beutler AS; Kanwar R; Ambulos N; Cavaletti G; Bruna J; Briani C; Argyriou AA; Kalofonos HP; Yerges-Armstrong LM; Dorsey SG
    J Pain Symptom Manage; 2017 Nov; 54(5):701-706.e1. PubMed ID: 28743660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protective effects of phosphatidylcholine on oxaliplatin-induced neuropathy in rats.
    Kim ST; Chung YH; Lee HS; Chung SJ; Lee JH; Sohn UD; Shin YK; Park ES; Kim HC; Bang JS; Jeong JH
    Life Sci; 2015 Jun; 130():81-7. PubMed ID: 25817232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the SOD mimetic MnL4 on in vitro and in vivo oxaliplatin toxicity: Possible aid in chemotherapy induced neuropathy.
    Di Cesare Mannelli L; Zanardelli M; Landini I; Pacini A; Ghelardini C; Mini E; Bencini A; Valtancoli B; Failli P
    Free Radic Biol Med; 2016 Apr; 93():67-76. PubMed ID: 26828020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute cold hypersensitivity characteristically induced by oxaliplatin is caused by the enhanced responsiveness of TRPA1 in mice.
    Zhao M; Isami K; Nakamura S; Shirakawa H; Nakagawa T; Kaneko S
    Mol Pain; 2012 Jul; 8():55. PubMed ID: 22839205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with the development and severity of oxaliplatin-induced peripheral neuropathy: a systematic review.
    Pulvers JN; Marx G
    Asia Pac J Clin Oncol; 2017 Dec; 13(6):345-355. PubMed ID: 28653815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxaliplatin-induced neuropathy occurs through impairment of haemoglobin proton buffering and is reversed by carbonic anhydrase inhibitors.
    Potenzieri A; Riva B; Rigolio R; Chiorazzi A; Pozzi E; Ballarini E; Cavaletti G; Genazzani AA
    Pain; 2020 Feb; 161(2):405-415. PubMed ID: 31634341
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2.
    Sprowl JA; Ciarimboli G; Lancaster CS; Giovinazzo H; Gibson AA; Du G; Janke LJ; Cavaletti G; Shields AF; Sparreboom A
    Proc Natl Acad Sci U S A; 2013 Jul; 110(27):11199-204. PubMed ID: 23776246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of drug transporters contributing to oxaliplatin-induced peripheral neuropathy.
    Fujita S; Hirota T; Sakiyama R; Baba M; Ieiri I
    J Neurochem; 2019 Feb; 148(3):373-385. PubMed ID: 30295925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TRPA1 and TRPM8 Receptors May Promote Local Vasodilation that Aggravates Oxaliplatin-Induced Peripheral Neuropathy Amenable to 17β-Estradiol Treatment.
    Pan Y; Chen F; Huang S; Cai Z; Lan H; Tong Y; Yu X; Zhao G
    Curr Neurovasc Res; 2016; 13(4):309-317. PubMed ID: 27262300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of oxidative stress and anti-oxidant treatment in platinum-induced peripheral neurotoxicity.
    Carozzi VA; Marmiroli P; Cavaletti G
    Curr Cancer Drug Targets; 2010 Nov; 10(7):670-82. PubMed ID: 20578989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ergothioneine ameliorates oxaliplatin-induced peripheral neuropathy in rats.
    Nishida K; Takeuchi K; Hosoda A; Sugano S; Morisaki E; Ohishi A; Nagasawa K
    Life Sci; 2018 Aug; 207():516-524. PubMed ID: 29981320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exenatide Facilitates Recovery from Oxaliplatin-Induced Peripheral Neuropathy in Rats.
    Fujita S; Ushio S; Ozawa N; Masuguchi K; Kawashiri T; Oishi R; Egashira N
    PLoS One; 2015; 10(11):e0141921. PubMed ID: 26536615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The usefulness of nerve conduction studies in objectively assessing oxaliplatin-induced peripheral neuropathy.
    Argyriou AA; Polychronopoulos P; Chroni E
    Oncologist; 2007 Nov; 12(11):1371-2; author reply 1372-3. PubMed ID: 18055858
    [No Abstract]   [Full Text] [Related]  

  • 34. Quantitative Sensory Testing at Baseline and During Cycle 1 Oxaliplatin Infusion Detects Subclinical Peripheral Neuropathy and Predicts Clinically Overt Chronic Neuropathy in Gastrointestinal Malignancies.
    Reddy SM; Vergo MT; Paice JA; Kwon N; Helenowski IB; Benson AB; Mulcahy MF; Nimeiri HS; Harden RN
    Clin Colorectal Cancer; 2016 Mar; 15(1):37-46. PubMed ID: 26337211
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxaliplatin-associated neuropathy: a review.
    Cersosimo RJ
    Ann Pharmacother; 2005 Jan; 39(1):128-35. PubMed ID: 15590869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A transient inflammatory response contributes to oxaliplatin neurotoxicity in mice.
    Calls A; Torres-Espin A; Tormo M; Martínez-Escardó L; Bonet N; Casals F; Navarro X; Yuste VJ; Udina E; Bruna J
    Ann Clin Transl Neurol; 2022 Dec; 9(12):1985-1998. PubMed ID: 36369764
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antioxidant effects of the flavonoids rutin and quercetin inhibit oxaliplatin-induced chronic painful peripheral neuropathy.
    Azevedo MI; Pereira AF; Nogueira RB; Rolim FE; Brito GA; Wong DV; Lima-Júnior RC; de Albuquerque Ribeiro R; Vale ML
    Mol Pain; 2013 Oct; 9():53. PubMed ID: 24152430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective HCN1 block as a strategy to control oxaliplatin-induced neuropathy.
    Resta F; Micheli L; Laurino A; Spinelli V; Mello T; Sartiani L; Di Cesare Mannelli L; Cerbai E; Ghelardini C; Romanelli MN; Mannaioni G; Masi A
    Neuropharmacology; 2018 Mar; 131():403-413. PubMed ID: 29339292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of axonal potassium conductance reduces nerve hyperexcitability in an in vitro model of oxaliplatin-induced acute neuropathy.
    Sittl R; Carr RW; Fleckenstein J; Grafe P
    Neurotoxicology; 2010 Dec; 31(6):694-700. PubMed ID: 20670646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of oxaliplatin-induced peripheral neuropathy by a polyamine-reduced diet-NEUROXAPOL: protocol of a prospective, randomised, controlled, single-blind and monocentric trial.
    Balayssac D; Ferrier J; Pereira B; Gillet B; Pétorin C; Vein J; Libert F; Eschalier A; Pezet D
    BMJ Open; 2015 Apr; 5(4):e007479. PubMed ID: 25833669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.